Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvar Agusti

Showing results (51-60 of 237) with videos related to

Pageof 24
Sort By:
Medicina Clinica|November 24, 2024
How could artificial intelligence improve patient experience in the ambulatory setting? Reflections from the JANUS groupOlga Rubio, Marc Vila, Manel Escobar, et al.
Medicina Clinica|August 9, 2022
JANUS proposals for the improvement of person's experience in outpatient clinicsAlvar Agusti, Esther Pallisa, Domingo Escudero, et al.
Thorax|July 13, 2014
Statins as adjunct therapy in COPD: how do we cope after STATCOPE?Robert P Young, Raewyn J Hopkins, Alvar Agusti
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2023
Treatable Traits in Airway Disease: From Theory to PracticeAlvar Agusti, Peter G Gibson, Vanessa M McDonald
The Lancet. Respiratory Medicine|January 15, 2021
Are women with asthma at increased risk for severe COVID-19?Mario Fernando, Alvar Agusti, Shyamali Dharmage, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 29, 2021
COVID-19 and COPD: lessons beyond the pandemicDavid M G Halpin, Claus F Vogelmeier, Alvar Agusti
Chest|June 1, 2013
Cardiovascular comorbidity in COPD: systematic literature reviewHana Müllerova, Alvar Agusti, Sebhat Erqou, et al.
The Lancet. Respiratory Medicine|September 26, 2022
Tackling the global burden of lung disease through prevention and early diagnosisAlvar Agusti, Claus F Vogelmeier, David M G Halpin
The European Respiratory Journal|September 8, 2018
Treatable traits in bronchiectasisRita Boaventura, Oriol Sibila, Alvar Agusti, et al.
The Lancet. Respiratory Medicine|July 22, 2018
Precision medicine in COPD exacerbationsAlvar Agusti, Rosa Faner, Bartolome Celli, et al.
Pageof 24

Showing results (51-60 of 237) with videos related to

Sort By:
Pageof 24
Medicina Clinica|November 24, 2024
How could artificial intelligence improve patient experience in the ambulatory setting? Reflections from the JANUS groupOlga Rubio, Marc Vila, Manel Escobar, et al.
Medicina Clinica|August 9, 2022
JANUS proposals for the improvement of person's experience in outpatient clinicsAlvar Agusti, Esther Pallisa, Domingo Escudero, et al.
Thorax|July 13, 2014
Statins as adjunct therapy in COPD: how do we cope after STATCOPE?Robert P Young, Raewyn J Hopkins, Alvar Agusti
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2023
Treatable Traits in Airway Disease: From Theory to PracticeAlvar Agusti, Peter G Gibson, Vanessa M McDonald
The Lancet. Respiratory Medicine|January 15, 2021
Are women with asthma at increased risk for severe COVID-19?Mario Fernando, Alvar Agusti, Shyamali Dharmage, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 29, 2021
COVID-19 and COPD: lessons beyond the pandemicDavid M G Halpin, Claus F Vogelmeier, Alvar Agusti
Chest|June 1, 2013
Cardiovascular comorbidity in COPD: systematic literature reviewHana Müllerova, Alvar Agusti, Sebhat Erqou, et al.
The Lancet. Respiratory Medicine|September 26, 2022
Tackling the global burden of lung disease through prevention and early diagnosisAlvar Agusti, Claus F Vogelmeier, David M G Halpin
The European Respiratory Journal|September 8, 2018
Treatable traits in bronchiectasisRita Boaventura, Oriol Sibila, Alvar Agusti, et al.
The Lancet. Respiratory Medicine|July 22, 2018
Precision medicine in COPD exacerbationsAlvar Agusti, Rosa Faner, Bartolome Celli, et al.
Pageof 24